UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000019426
Receipt No. R000022467
Official scientific title of the study A study of dermatological efficacy after continuous application of topical product (BSL02-1509AYM) in human skin
Date of disclosure of the study information 2015/10/30
Last modified on 2016/10/20 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study A study of dermatological efficacy after continuous application of topical product (BSL02-1509AYM) in human skin
Title of the study (Brief title) A study of dermatological efficacy after continuous application of topical product (BSL02-1509AYM) in human skin
Region
Japan

Condition
Condition Healthy adults
Classification by specialty
Dermatology Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Evaluation of skin condition by stratum corneum water content, transepidermal water loss, skin pH, photo image in skin surface, skin color, analysis of lipidome and metaborome in horny cell layer, evaluation of vascular function after repeated application of topical product for 4 and 8 weeks
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Evaluation of skin condition by stratum corneum water content, transepidermal water loss, skin pH, photo image in skin surface, skin color, analysis of lipidome and metaborome in horny cell layer, evaluation of vascular function after repeated application of topical product for 4 and 8 weeks
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Other
Interventions/Control_1 Topical application of both test product and control product for 4weeks and 8weeks.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
60 years-old >=
Gender Male
Key inclusion criteria 1)Healthy males
2)Individuals who drink only a few cup of coffee per day
Key exclusion criteria 1)Individuals who have some skin diseases (atopic dermatitis and so on)
2)Individuals who have some skin troubles in applied positions
3)Individuals who already got dark skin with excessive sunburn
4)Individuals who play outdoor actions with excessive sunburn routinely
5)Individuals who apply cosmetics or drugs for beauty to target skins, and take drugs for improvement of fleck, age spot and suntan
6)Individuals who have some diseases (endocrine, liver, kidney, heart and blood pressure and so on), or have had some diseases until a month
7)Individuals who have some diseases (hypertension, cardiac disease, diabetes, Raynaud disease, rosacea, telangiectasia) or feel excessive sensitivity to cold
8)Individuals who have an abnormal cardiac rhythm
9)Individuals who usually take some medications
10)Individuals who got some cosmetic surgery/implant
11)Individuals who have or might have same dermatological diseases (pollen, rhinitis, and allergic dermatitis)
12)Individuals who have or might have same allergy of medicine
13)Smoker
14)Individuals who drink much coffee per day
15)Individuals who are judged inappropriate for the study by study director and/or study doctor
Target sample size 20

Research contact person
Name of lead principal investigator Takatoshi Murase
Organization Kao Corporation
Division name R&D -Core Technology- Biological Science Research
Address 2606, Akabane, Ichikai-machi, Haga-gun, Tochigi, 321-3497, JAPAN
TEL 0285-68-7871
Email murase.takatoshi@kao.co.jp

Public contact
Name of contact person Katsuyuki Yuki
Organization Kao Corporation
Division name R&D -Core Technology- Biological Science Research
Address 2606, Akabane, Ichikai-machi, Haga-gun, Tochigi, 321-3497, JAPAN
TEL 0285-68-7460
Homepage URL
Email yuki.katsuyuki@kao.co.jp

Sponsor
Institute Kao Corporation
Institute
Department

Funding Source
Organization Kao Corporation
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 花王株式会社(栃木県)

Other administrative information
Date of disclosure of the study information
2015 Year 10 Month 30 Day

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 10 Month 20 Day
Anticipated trial start date
2015 Year 11 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 10 Month 20 Day
Last modified on
2016 Year 10 Month 20 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022467